FNA (Paragon 28 Inc.) Bozor qiymatining balans qiymatiga nisbati

Paragon 28 (FNA) - korporativ logo

Steril to'plamlarning klinikalarga samarali yetkazib berilishi xarajatlarni minimallashtiradi va jarrohlik xavfsizligini kafolatlaydi. Kitob qiymatiga nisbatan narx koeffitsiyenti bozor premiumi tendentsiyasini vizuallashtiradi, bunda 8.48 ushbu parametrning miqdorini aks ettiradi. Implantlarning keng assortimenti va global distribyutsiya xatarlarni yumshatadi, sohaning makroiqtisodiyotdan mustaqilligi esa Paragon 28, Inc. (FNA) kompaniyasini ishonchli defensiv aktivga aylantiradi.

FNA - paragon28.com Bozor qiymatining balans qiymatiga koeffitsiyenti 04.07.2022 - 26.04.2025 oraligʻida

FNA (Paragon 28, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi paragon28.com|FNA - Tahlilchilar median maqsadi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Paragon 28 Corp|FNA - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Paragon 28|FNA - Kompaniyaning xususiy kapitali|Bozor kapitallashuvining balans qiymatiga nisbati paragon28.com|FNA - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Paragon 28, Inc.|FNA - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati paragon28.com|FNA - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Paragon 28 Corp|FNA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzlari Paragon 28
Fundamental baholash:Paragon 28, Inc.
Paragon 28, Inc. tomonidan chiqariladigan mahsulotlar

Ushbu koeffitsient sof aktivlardan yuqori bo'lgan bozor qiymati premiyasini o'lchaydi va investorlarning kelajakdagi daromadlar bo'yicha kutganlarini aks ettiradi. Qiymatning oshishi biznesning haddan tashqari yuqori baholanganligini anglatadi, qiymatning kamayishi esa kapitalning past baholanganligini ko'rsatadi. Balans hisoboti bilan nisbatan bozor kapitalizatsiyasi baholash tendentsiyasini tahlil qilish orqali 8.48 ning joriy darajasini kuzatish mumkin. Ushbu premiya intellektual kapitalning yuqori qiymati bilan belgilanadi. Paragon 28, Inc. (FNA) kompaniyasining innovatsion salohiyati yuqori malakali biomeditsina mutaxassislari jamoasi va sezilarli R&D investitsiyalari bilan ta'minlangan.

Raqobatchilar tahlili

Boston Scientific - Bozor qiymatining balans qiymatiga nisbati|EW (edwards.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati ResMed RMD|Sof aktivlarga nisbatan bozor kapitallashuvi Insulet Corp|Zimmer Biomet Holdings, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti CooperSurgical (COO)|Align Technology, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati globusmedical.com GMED|Bozor kapitallashuvining balans qiymatiga nisbati TMDX (TransMedics Group)|ATEC - Balans qiymatiga nisbatan bozor kapitallashuvi|AORT: Bozor kapitallashuvining balans qiymatiga nisbati|ENOV (Enovis Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Integra LifeSciences|Bozor qiymatining balans qiymatiga nisbati establishmentlabs.com|BBNX (Beta Bionics) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi IRADIMED Corp IRMD|Embecta Inc. (EMBC) - Kapitallashuvning sof aktivlarga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Tandem Corp TNDM|AXGN (AxoGen, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|SIBN - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati Orthofix|Kapitallashuvning balans qiymatiga nisbati Bioventus Inc|KIDS - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TMCI|Bozor qiymatining balans qiymatiga nisbati SRTA (Strata Critical Medical Inc)|Kapitallashuvning sof aktivlarga nisbati carlsmed.com (CARL)|RXST: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ClearPoint Neuro Inc. CLPT|Stereotaxis Corp (STXS) - Bozor kapitallashuvining balans qiymatiga nisbati|STIM - Kapitallashuvning balans qiymatiga nisbati|Sight Sciences, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|orchestrabiomed.com (OBIO) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ANIK|Kapitallashuvning sof aktivlarga nisbati InspireMD Inc|Bozor kapitallashuvining balans qiymatiga nisbati ZJYL|Bozor kapitallashuvining balans qiymatiga nisbati VANI (vivani.com)|Bozor qiymatining balans qiymatiga nisbati Xtant Medical XTNT|NMTC - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Modular Med (MODD)|MYO - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati COCH|VVOS (Vivos Therapeutics Inc) - Bozor qiymatining balans qiymatiga koeffitsiyenti|enVVeno Medical - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati SINTX Technologies (SINT)|Kapitallashuvning sof aktivlarga nisbati TNON|Bozor kapitallashuvining balans qiymatiga nisbati ReWalk Robotics (LFWD)|Bozor kapitallashuvining balans qiymatiga nisbati AMIX|INVO Fertility Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Bone Biologics|AXNX: Sof aktivlarga nisbatan bozor kapitallashuvi|BIOL (BIOLASE) - Bozor qiymatining balans qiymatiga nisbati|Dynatronics (DYNT) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati INVO (INVO Bioscience Inc.)